Hepatitis C Virus Infection among HIV-Infected Patients Attending Dessie Referral Hospital, Northeastern Ethiopia
Table 2
Anti-HCV positivity in relation to HCV risk factors and sociodemographic factors among HIV-infected patients at Dessie Referral Hospital, Northeastern Ethiopia, 2018.
Variables
HCV antibody
COR (95% CI)
value
AOR (95%CI)
value
Positive no. (%)
Negative no. (%)
Knowledge of HCV causative agent
Yes
3(3.2)
90(96.8)
1
No
10(6.4)
146(93.6)
2.055 (0.551, 7.666)
0.284
NA
Knowledge of the mode of transmission
Yes
1(2.0)
49(98.0)
1
No
12(6.0)
187(94.0)
3.144 (0.399, 24.772)
0.277
NA
History of hospitalization
Yes
10(13.2)
66(86.8)
8.586 (2.291, 32.177)
0.001
10.234 (2.049, 51.118)
0.005
No
3(1.7)
170(98.3)
1
Previous surgical history
Yes
2(8.3)
22(91.7)
1.769 (0.368, 8.495)
0.476
NA
No
11(4.9)
214(95.1)
1
History of skin disorder
Yes
5(5.6)
85(94.4)
1.110 (0.352, 3.501)
0.858
NA
No
8(5.0)
151(95.0)
1
History of circumcision
Yes
7(5.1)
131(94.9)
0.935 (0.305, 2.867)
0.907
NA
No
6(5.4)
105(94.6)
1
History of blood transfusion
Yes
3(5.3)
54(94.7)
1.011 (0.269, 3.806)
0.987
NA
No
10(5.2)
182(94.8)
1
History of unsafe sexual intercourse
Yes
6(6.3)
89(93.7)
1.416 (0.461, 4.347)
0.544
NA
No
7(4.5)
147(95.5)
1
History of tooth extraction
Yes
4(17.4)
19(82.6)
5.076 (1.429, 18.034)
0.012
6.016 (1.137, 36.837)
0.048
No
9(4.0)
217(96.0)
1
Sharing of sharp material with friends
Yes
1(7.1)
13(92.9)
1.429 (0.172, 11.853)
0.741
NA
No
12(5.1)
223(94.9)
1
Smoking habit
Yes
2(8.3)
22(91.7)
1.606 (0.336, 7.679)
0.553
NA
No
13(5.8)
212(94.2)
1
Drinking habit
Yes
3(4.9)
58(95.1)
0.921 (0.245, 3.460)
0.903
NA
No
10(5.3)
178(94.7)
1
Liver disease
Yes
3(25)
9(75)
7.567 (1.771, 32.323)
0.006
11.398 (1.275, 101.930)
0.029
No
10(4.2)
227(95.8)
1
Duration of HIV infection from diagnosis
>10 years
12(6.9)
161(93.1)
5.590 (0.714, 43.786)
0.101
4.934 (0.463, 52.548)
0.186
<10 years
1(1.3)
75(98.7)
1
Duration of HIV treatment
>10 years
8(11.6)
61(88.4)
3.905 (1.241, 34.546)
0.021
5.490 (1.341, 34.458)
0.041
<10 years
5(2.8)
175(97.2)
1
WHO clinical stage
I/II
5(2.6)
184(97.4)
1
III/IV
8(13.3)
52(86.7)
5.662 (1.777, 18.041)
0.003
12.768 (2.293, 71.106)
0.004
CD4+ category, cells/mm3
≤200
5(4.5)
106(95.5)
0.767 (0.244, 2.412)
0.649
0.559 (0.120, 2.598)
0.458
>200
8(5.8)
130(94.2)
1
Sex
Male
10(8.4)
109(91.6)
3.884 (1.042, 14.471)
0.043
4.555 (0.842, 24.655)
0.078
Female
3(2.3)
127(97.7)
1
Age
≤50 years
9(4.4)
208(95.9)
1
>50 years
4(12.5)
28(87.5)
3.302 (0.953, 11.433)
0.059
9.070 (1.578, 52.117)
0.013
Statistically significant at . AOR: adjusted odds ratio, COR: crude odds ratio, 1: reference group, 95% CI: 95% confidence interval, HCV: Hepatitis C Virus, HIV: Human Immunodeficiency Virus, NA: not applicable, WHO: World Health organization.
